Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROspective Study to OPTimize thE HEALTH of Patients With TIAS (Transient Ischemic Attack) and Stroke Admitted to the Hamad General Hospital

NCT02868723 is registered in ClinicalTrials.gov with Hamad Medical Corporation as lead sponsor.

NCT NCT02868723
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02868723 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROspective Study to OPTimize thE HEALTH of Patients With TIAS (Transient Ischemic Attack) and Stroke Admitted to the Hamad General Hospital
Lead sponsor
Hamad Medical Corporation
Phase
Not applicable
Overall status
Unknown status
Start date
November 12, 2017
Completion date
December 30, 2019
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke, transient ischemic attack (tia)